CRT Meeting(@CRT_meeting) 's Twitter Profileg
CRT Meeting

@CRT_meeting

#CRT2025 is an interventional cardiology meeting comprised of concurrent meetings in 10 areas of interest. Visit our website for more information.

ID:59501086

linkhttp://crtmeeting.org calendar_today23-07-2009 15:47:40

8,3K Tweets

10,2K Followers

8,3K Following

CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

The use of intravascular ultrasound guidance significantly improved the outcomes of DCB treatment for femoropopliteal artery disease, a Medtronic and Korea United Pharm-funded study suggests. Read more on . . crtonline.org/news-detail/ne…

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

Long-term MACE are reduced in patients with non-flow-limiting vulnerable plaques who undergo preventative plus optimal medical therapy, compared with only optimal medical therapy, the PREVENT trial shows. Read more on . . crtonline.org/news-detail/ne…

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

ATLANTA – Alcohol-mediated RDN showed a “modest but significant” decrease in 24-hour ambulatory systolic blood pressure compared to a sham procedure at 3 months, meeting the primary endpoint, according to TARGET BP I results. . . ow.ly/XSih50Rw9iV

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

ATLANTA – with operator’s choice of prosthesis was noninferior to concerning the composite of all-cause mortality or stroke at 1 year in patients with severe, symptomatic AS at low to intermediate surgical risk. . . ow.ly/7gbX50Rw91y

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

A coronary sinus reducer improves angina compared with placebo, according to a new study, in which researchers also found the device did not improve transmural myocardial perfusion. Read more on . . ow.ly/ARY750Rw5kl

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

A web-based app determined patients’ suitability for non-prescription statins in agreement with clinician assessment for more than 90% of cases in a phase III study presented Monday at the ACC Annual Scientific Sessions. Read more on . . ow.ly/MBNi50Rw07j

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

SAVE THE DATE! Registration for is now open. Join us from March 8-11, 2025, for 4 days of your favorite topics and sessions in . Go to crtmeeting.org and register now.

fellow nurse

SAVE THE DATE! Registration for #CRT2025 is now open. Join us from March 8-11, 2025, for 4 days of your favorite topics and sessions in #cardiology. Go to crtmeeting.org and register now. #cardiologyfellow #cardiologynurse #interventionalcardiology
account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

ATLANTA – Topical tranexamic acid (TxA) did not reduce the risk of seizure – and increased the risk of blood transfusion – compared with standard intravenous TxA in patients undergoing cardiac surgery. Read more on . . ow.ly/vjTS50RvYP4

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

ATLANTA – A novel program that introduced standalone chest pain units throughout the “mega-city” of Karachi, Pakistan, has improved timely access to primary and could serve as a blueprint for other developing countries. Read more on . ow.ly/t17M50RvY8U

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

The use of a liberal transfusion strategy may be particularly impactful in type 1 patients with anemia, according to a prespecified subgroup analysis of data from the MINT trial that reports a trend toward better outcomes. . crtonline.org/news-detail/ne…

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

Join us 7:30 AM ET Wed. for cath conference. Leonhard Binzenhöfer, MD, will discuss scrutinizing VA-ECMO. Norman Mangner, MD, will discuss protecting arteries according to anatomical requirements in valve-in-valve .

Email [email protected] for a link.

Join us 7:30 AM ET Wed. for cath conference. Leonhard Binzenhöfer, MD, will discuss scrutinizing VA-ECMO. Norman Mangner, MD, will discuss protecting #coronary arteries according to anatomical requirements in valve-in-valve #TAVR. Email mwhc.cathconference@gmail.com for a link.
account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

Postoperative delirium incidence is not reduced while restricting benzodiazepines during , according to an intention-to-treat analysis. Read more on . . crtonline.org/news-detail/ne…

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

ACS patients who stopped aspirin alongside ticagrelor 1 month post- saw a significantly reduced risk of bleeding, with no increased risk of clotting-related adverse events, at 12 months compared with patients who continued DAPT for a full year. ow.ly/cfj650RvMcQ

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

Implantation of the Impella CP micro-axial flow pump after a heart attack significantly increased survival rates at 6 months in people suffering , the DanGer Shock Trial concludes. Read more on . . ow.ly/6uuW50RvLFt

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

Long-term beta-blocker treatment is not associated with a lower risk of death from any cause or new in patients with acute MI with preserved LVEF (≥50%), a new study shows. Read more on . . ow.ly/XU4J50RvKAc

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

No significant clinical benefits come from edetate disodium chelation, though chelation led to >60% reduction in blood lead levels as compared to placebo, results from the TACT2 trial show. Read more on . . ow.ly/L5zX50RvJvM

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

A remote telemedicine-based approach for the management of patients following ACS was associated with a reduction in hospital readmission, ED visits, unplanned and patient-reported symptoms. Read more on . ow.ly/V4xu50RvbGx

account_circle
CRT Meeting(@CRT_meeting) 's Twitter Profile Photo

4 weekly infusions of the novel human apoA-I CSL112 didn't significantly reduce 90-day incidence of death, or stroke compared to placebo, in patients with multivessel disease and other risk factors, according to the AEGIS-II Trial. crtonline.org/news-detail/ae…

account_circle